Carolyn F. Bonner, President and CFO of Medicus Pharma Ltd. (NASDAQ:MDCX), filed a Form 4 on November 17, 2026, disclosing the acquisition of 29,069 common shares on November 13, 2026, through a private placement subscription agreement.

Key Highlights

  • Reporting person: Carolyn F. Bonner, President and CFO of Medicus Pharma Ltd.
  • Transaction: Acquisition (Code A) of 29,069 common shares, no par value, at $1.72 per share
  • Transaction date: November 13, 2026, via a private placement subscription agreement
  • Beneficial ownership following transaction: 58,859 common shares held directly
  • Other participants: According to the filing, other investors also participated in the same private placement under separate subscription agreements
  • Filing signed: By Raza Bokhari, as Attorney-in-Fact for Carolyn F. Bonner, on November 17, 2026

Medicus Pharma CFO Enters Subscription Agreement in Private Placement

According to the Form 4 filed with the SEC, Carolyn F. Bonner, serving as President and CFO of Medicus Pharma Ltd., acquired 29,069 common shares, no par value, at a purchase price of $1.72 per share on November 13, 2026. The filing describes the transaction as arising from a subscription agreement entered into directly between Ms. Bonner and the issuer.

The filing's explanation of responses states: "On November 13, 2026, Carolyn F. Bonner entered into a subscription agreement with the Issuer, pursuant to which Ms. Bonner agreed to purchase 29,069 common shares, no par value, at a purchase price of $1.72 per share in a private placement in which other investors also participated under separate subscription agreements." The transaction is reported as an acquisition (Code A) of non-derivative securities in Table I of the form.

Following the reported transaction, the filing discloses that Ms. Bonner directly holds 58,859 common shares of Medicus Pharma Ltd. No derivative securities transactions were reported in Table II. The Form 4 was signed by Raza Bokhari as Attorney-in-Fact for Ms. Bonner and filed on November 17, 2026.

What Was Disclosed

Medicus Pharma Ltd. (NASDAQ:MDCX) President and CFO Carolyn F. Bonner disclosed the purchase of 29,069 common shares at $1.72 per share through a private placement on November 13, 2026, bringing her directly held beneficial ownership to 58,859 shares.